Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tandem Diabetes (TNDM) Tops Q4 EPS by 11c, Offers FY Guidance
February 24, 2016 4:15 PM ESTTandem Diabetes (NASDAQ: TNDM) reported Q4 EPS of ($0.40), $0.11 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $29.1 million versus the consensus estimate of $29.17 million.
GUIDANCE:
Tandem Diabetes sees FY2016 revenue of $105-112 million, versus... More
